Literature DB >> 32186270

Expression of P-gp in Glioblastoma: What we can Learn from Brain Development.

Ignazio de Trizio1, Mariella Errede2, Antonio d'Amati2, Francesco Girolamo2, Daniela Virgintino2.   

Abstract

P-Glycoprotein (P-gp) is a 170-kDa transmembrane glycoprotein that works as an efflux pump and confers multidrug resistance (MDR) in normal tissues and tumors, including nervous tissue and brain tumors. In the developing telencephalon, the endothelial expression of P-gp, and the subcellular localization of the transporter at the luminal endothelial cell (EC) plasma membrane are an early hallmark of blood-brain barrier (BBB) differentiation, and suggest a functional BBB activity that may complement the placental barrier function and the expression of P-gp at the blood-placental interface. In early fetal ages, P-gp has also been immunolocalized on radial glia cells (RGCs), located in the proliferative ventricular zone (VZ) of the dorsal telencephalon and now considered to be neural progenitor cells (NPCs). RG-like NPCs have been found in many regions of the developing brain and have been suggested to give rise to neural stem cells (NSCs) of adult subventricular (SVZ) neurogenic niches. The P-gp immunosignal, associated with RG-like NPCs during cortical histogenesis, progressively decreases in parallel with the last waves of neuroblast migrations, while 'outer' RGCs and the deriving astrocytes do not stain for the efflux transporter. These data suggest that in human glioblastoma (GBM) P-gp expressed by ECs may be a negligible component of tumor MDR. Instead, tumor perivascular astrocytes may dedifferentiate and resume a progenitor-like P-gp activity, becoming MDR cells and contribute, together with perivascular P-gp-expressing glioma stem-like cells (GSCs), to the MDR profile of GBM vessels. In conclusion, the analysis of P-gp immunolocalization during brain development may contribute to identify the multiple cellular sources in the GBM vessels that may be involved in P-gp-mediated chemoresistance and can be responsible for GBM therapy failure and tumor recurrence. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Adult brain; Astrocytes; Blood-brain barrier; Developing brain; Endothelial cells; Glioblastoma; Glioma stem cells; P-glycoprotein; Radial glia-like neural progenitor cells

Year:  2020        PMID: 32186270     DOI: 10.2174/1381612826666200318130625

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  Changes in the vasculature of human brain tumors: Implications for treatment.

Authors:  Wenjuan Zhang; Surabhi Talele; Jann N Sarkaria; William F Elmquist
Journal:  Neuro Oncol       Date:  2021-12-01       Impact factor: 13.029

2.  Double Immunohistochemical Staining on Formalin-Fixed Paraffin-Embedded Tissue Samples to Study Vascular Co-option.

Authors:  Tiziana Annese; Mariella Errede; Michelina De Giorgis; Loredana Lorusso; Roberto Tamma; Domenico Ribatti
Journal:  Methods Mol Biol       Date:  2023

Review 3.  NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review).

Authors:  Zhaomu Zeng; Yueyue Chen; Xiuchao Geng; Yuhao Zhang; Xichao Wen; Qingyu Yan; Tingting Wang; Chen Ling; Yan Xu; Junchao Duan; Kebin Zheng; Zhiwei Sun
Journal:  Int J Oncol       Date:  2022-05-04       Impact factor: 5.884

Review 4.  Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for Glioblastoma.

Authors:  Ioannis Ntafoulis; Stijn L W Koolen; Sieger Leenstra; Martine L M Lamfers
Journal:  Cancers (Basel)       Date:  2022-07-29       Impact factor: 6.575

Review 5.  The Effects of Environmental Adversities on Human Neocortical Neurogenesis Modeled in Brain Organoids.

Authors:  Kseniia Sarieva; Simone Mayer
Journal:  Front Mol Biosci       Date:  2021-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.